Sophrosyne Capital’s Syneron Medical Ltd ELOS Stock Holding History

Sophrosyne Capital’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-71,300	Closed	-$713K	–	59
2014 Q3	$713K	Buy	+71,300	New	+$725K	0.84%	33

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Sophrosyne Capital's ELOS Position: Q4 2014 in Review

Sophrosyne Capital sold out of Syneron Medical Ltd (ELOS) in Q4 2014, closing a stake of 71,300 shares — an estimated $713K sold.

Sophrosyne Capital first reported a position in ELOS in Q3 2014 and held it in 1 quarter. The position peaked at $713K in Q3 2014. 68 funds tracked by Wall St. Rank hold ELOS as of Q4 2014.

Sophrosyne Capital reported no remaining Syneron Medical Ltd position as of Q4 2014 after selling out during the quarter.
Sophrosyne Capital sold 71,300 Syneron Medical Ltd shares in Q4 2014, an estimated $713K.
Sophrosyne Capital first reported a position in Syneron Medical Ltd in Q3 2014 and held it in 1 quarter.
Sophrosyne Capital's Syneron Medical Ltd position peaked at $713K in Q3 2014.
68 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2014.

Based on Sophrosyne Capital's 13F filing for Q4 2014, filed 26 Jan 2015.